Faraone Stephen V, Wilens Timothy E
Department of Psychiatry and the Department of Behavioral Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY 13210, USA.
J Clin Psychiatry. 2007;68 Suppl 11:15-22.
The objective of this article is to review literature about the effects of stimulant therapy on substance use disorders and the potential for misuse and diversion of stimulants. We reviewed published literature relevant to these objectives, and studies were selected if they were published or accepted for publication in peer-reviewed journals. Prospective longitudinal studies show that attention-deficit/hyperactivity disorder (ADHD) is a risk factor for subsequent substance use disorders. These studies also suggest that ADHD pharmacotherapy in childhood reduces the risk for substance use disorders. Misuse and diversion of prescribed stimulants occur among a minority of ADHD patients, especially those with conduct or substance use disorders. Long-acting stimulants may be less likely to be misused or diverted.
本文的目的是回顾关于兴奋剂治疗对物质使用障碍的影响以及兴奋剂滥用和转移的可能性的文献。我们回顾了与这些目标相关的已发表文献,入选的研究需发表于同行评审期刊或已被同行评审期刊接受发表。前瞻性纵向研究表明,注意力缺陷多动障碍(ADHD)是后续物质使用障碍的一个风险因素。这些研究还表明,儿童期ADHD药物治疗可降低物质使用障碍的风险。少数ADHD患者会出现处方兴奋剂的滥用和转移,尤其是那些有品行障碍或物质使用障碍的患者。长效兴奋剂被滥用或转移的可能性可能较小。